Diabetes complications and comorbidities

Bone health

06-15-2019 | Bone health | Article

Analysis of fractures in patients with type 2 diabetes treated with empagliflozin in pooled data from placebo-controlled trials and a head-to-head study versus glimepiride

Kohler S et al. Diabetes Care 2018: dc171525. doi: 10.2337/dc17-1525

01-02-2019 | Canagliflozin | medwireNews | News

No fracture risk found with canagliflozin in real-world data

Research based on insurance claims data indicates that new users of the sodium-glucose cotransporter-2 inhibitor canagliflozin are no more likely to experience a fracture than new users of glucagon-like peptide-1 receptor agonists.

Source:: Ann Intern Med 2019; doi:10.7326/M18-0567
Ann Intern Med 2019; doi:10.7326/M18-3550

08-18-2018 | Bone health | Review | Article

Lifestyle management of diabetes: implications for the bone-vascular axis

Pieralice S et al. Curr Diab Rep 2018; 18: 84. doi: 10.1007/s11892-018-1060-y

07-23-2018 | SGLT2 inhibitors | Review | Article

SGLT2 inhibitors in type 2 diabetes management: Key evidence and implications for clinical practice

Wilding J et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0471-8

07-06-2018 | Osteoporosis | Article

FRAX tool in type 2 diabetic subjects: The use of HbA1c in estimating fracture risk

Valentini A et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1187-y

04-25-2018 | Bone health | Review | Article

Diabetes mellitus and bone health: Epidemiology, etiology and implications for fracture risk stratification

Valderrábano RJ, Linares MI. Clin Diabetes Endocrinol 2018; 4: 9. doi: 10.1186/s40842-018-0060-9

02-06-2018 | Osteoporosis | Review | Article

Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: A systematic review

Anagnostis P et al. Endocrine 2018; Advance online publication. doi: 10.1007/s12020-018-1548-x

01-20-2018 | Osteoporosis | Article

Comparison of osteoporosis in US adults with type 1 and type 2 diabetes mellitus

DeShields SC, Cunningham TD. J Endocrinol Invest 2018; Advance online publication. doi: 10.1007/s40618-018-0828-x

04-27-2017 | Osteoporosis | Review | Article

Diabetes, bone and glucose-lowering agents: Clinical outcomes

Schwartz AV. Diabetologia 2017; 60: 1170–1179. doi: 10.1007/s00125-017-4283-6

04-22-2017 | Osteoporosis | Review | Article

Diabetes, bone and glucose-lowering agents: Basic biology

Lecka-Czernik B. Diabetologia 2017; 60: 1163–1169. doi: 10.1007/s00125-017-4269-4

03-14-2017 | Bone health | Article

Imaging of diabetic bone

Ponti F et al. Endocrine 2017; 3: 426–441. doi: 10.1007/s12020-017-1278-5

03-09-2017 | Osteoporosis | Review | Article

Obesity, type 2 diabetes, and bone in adults

Walsh JS, Vilaca T. Calcif Tissue Int 2017; 100: 528–535. doi: 10.1007/s00223-016-0229-0

More on diabetes complications and comorbidities

image credits

Medicine Matters Diabetes